ArticleEuropean journal of medicinal chemistry2024
Discovery and optimization of narrow spectrum inhibitors of Tousled like kinase 2 (TLK2) using quantitative structure activity relationships.
Christopher R M Asquith et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.